Warning Letter — Conroe Welding Supply, Inc.
The FDA issued a Warning Letter to Conroe Welding Supply, Inc. following an inspection by the Center for Drug Evaluation and Research (CDER).
This affects Conroe Welding Supply, Inc., specifically their quality and manufacturing personnel involved in medical gas production, as well as regulatory professionals overseeing medical gas compliance.
The issuance of a Warning Letter by CDER indicates significant deviations from CGMP regulations. For firms in the medical gas sector, this suggests that the FDA is maintaining oversight of gas manufacturing processes and documentation standards. Failure to address these findings could lead to further enforcement actions such as seizures or injunctions.
Review Current Good Manufacturing Practice (CGMP) compliance for medical gas filling operations. Ensure all quality control procedures, documentation, and facility standards align with CDER requirements for drug manufacturing. Conduct internal audits of gas production and distribution records.
FDA Warning Letter issued to: Conroe Welding Supply, Inc.. 10/29/2026 — Center for Drug Evaluation and Research (CDER). Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/conroe-welding-supply-inc-731507-10292026
Open in openFDA / FDA.gov